BioHemp International, Inc. (OTC: BKIT)

Updated: July 19, 2019

BKIT Provides Short Interview Updates on Current Status of Company, and Plans Going Forward

(NEW YORK)--Daniel Blum, the CEO of BioHemp International (OTC: BKIT) provided us a short interview update on BKIT, and for plans going forward with the company.

Below is a short written interview conducted with Daniel Blum, the CEO of BioHemp International, Inc. (OTC:BKIT) on Friday, July 19, 2019. For future updates, or to be added to BKIT investor mailing list, please register below to request an investor packet on the company by mail.

WSNC: There has been a lot of chatter and events recently with BioHemp, and I was wondering if you could give us a quick update and address where things stand currently. Obviously main issue everyone seems to be concerned about was the recent sharp drop in BKIT share price, which I gather came about on some misinterpreted information regarding share structure. Can you give us a quick update on what exactly happened, and what the current situation is as of now?

Daniel Blum: Of course, I completely understand why shareholders were confused and furious with the sudden drop price. Last week Friday we released our 8-K and the way we published it was very confusing. To clear up any confusion, the company has not added an additional 25 million shares, the current share structure has remains at 28.8 million outstanding.

Rest assured, we have been taking steps so something like this doesn’t happen again in the future as we aim to be as transparent as possible in these sorts of things as we move forward. Our goal, or safe to say my goal, is to work on building back confidence in the story we are building here by reaching out to shareholders and engaging in media forums such as this to get out there and tell our story. As CEO selling our corporate story to the investment community is one of my primary jobs, and that is what I plan to do.


WSNC: The company’s main focus is building assets and distribution channels for the CBD sector. Now obviously I'm sure you may be limited to what you can announce detail-wise until they are closed, but is this still the plan, and how soon before we may start seeing news on this roll-up strategy start to be announced publicly?

Daniel Blum: I’m excited with some of the recent acquisitions and new deals we are moving towards every day. I can’t say exactly what the new name of the company is but we recently acquired an e-commerce platform. The news should be announced on this coming Monday and we should also have more news regarding our strategy in the coming weeks.


WSNC: I guess the main question to lay out is one of confidence. Many shareholders had great concerns, and rightfully so based on the dramatic drop in share price. So I was wondering can you lay out to shareholders what are your plans specifically to rebuild confidence in BKIT going forward.

Daniel Blum: Of course, what happened Friday was unprofessional and inexcusable. Moving forward shareholders will have a more direct way to reach me as well a better way to stay on top of exactly what BKIT is doing. We will have a new distribution list that will ensure every shareholder will be able to obtain the information they desire. As well the shareholders will see a stronger social media presence. We have many new exciting things developing in the coming weeks and I know our shareholders once announced we also be excited.


WSNC: Finally, is there a point of contact or specific way to contact the company directly to address their concerns during these times. Maybe a direct number of email they can reach out to with their questions?

Daniel Blum: Yes as mentioned previously I want my shareholders to know that I am available to them. Shareholder communication is by far the most important factor in building confidence with your shareholders, and potential new investors. For this reason we want to fully open the door for investors to reach out to the company with any questions or concerns they may have. They can reach me directly through my personal cell number: 914-806-1850 or they can email me:

Transfer Agent Confirmation

100,000,000 Authorized Common Shares
28,850,700 Total Outstanding Common Shares
25,021,000 Total Restricted Common Shares
Public float 3.8 million Common Shares

If needed in the future you can contact me directly with requests of this type.

Client Services Representative
Pacific Stock Transfer
800-785-7782 Toll Free Phone


About BioHemp International, Inc.

BioHemp International (OTC: BKIT) is a Company focused on rolling up a distribution platform for CBD providers to become the leading consolidation force in the CBD industry. For more information, view the Company’s website


This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Trader Madness does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. In Compliance with SEC Rule 17B Trader Madness was compensated two thousand three hundred dollars for on going media services. Trader Madness, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. As of date of this alert, Trader Madness, or any of its affiliates, held no positions in securities mentioned above. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.
Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
High Risk
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial advisor before making any and all investment decisions when investing in these type of securities